Bright Minds Biosciences Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| DRUG | ANRO | MPLT | ATAI | SPRB | NGNE | |
|---|---|---|---|---|---|---|
| Market cap | 187.02M | 914.34M | 372.91M | — | 133.96M | 551.91M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.5 | -7.3 | -2.0 | — | 9.4 | -4.8 |
| Price/book | 0.9 | 3.7 | 0.9 | — | 1.5 | 2.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −66.21% | +109.34% | −58.43% | — | −64.33% | +3.45% |
| Today | −12.02% | +2.64% | −1.47% | 0.00% | +8.88% | +3.41% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DRUG news ›Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 6.6% – Here’s What Happened
Posted by Michael Walen on Oct 15th, 2026 Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Free Report) shares were up 6.6% on Thursday. The company traded as high as $53.56 and last traded at $54.0420. 7,996 shares were traded during…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com2
- tipranks.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.